NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Zydus Lifesciences has introduced REVAHALE, the first once-daily nebulised Long-Acting Muscarinic Antagonist (LAMA) in India for COPD maintenance. This launch addresses a critical gap for patients who struggle with handheld inhalers, offering sustained 24-hour bronchodilation.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
